Use of a Glycine B partial agonist as an antipsychotic

Details Use of a Glycine B partial agonist as an antipsychotic Use of a Glycine B partial agonist as an antipsychotic

1989-01-09

1993-02-16

Friedman, S. J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514378, A61K 3141, A61K 3142

Patent

active

051871718

ABSTRACT:
A class of Glycine B partial agonists is described for use for treatment of psychosis. Preferred Glycine B partial agonists include amino-isoxazolidone compounds such as D-cycloserine and its prodrugs.

REFERENCES:
C. V. Showalter et al., Amer. J. Psychiat., 134, 1234 (1977).
S. H. Snyder, Nature, 285, 355-356 (1980).
P. Loo et al., Eur. J. Pharmacol, 123, 467-468 (1986).
C. A. Tamminga et al., Synapse, 1, 497-504 (1987).
R. Quirion et al, Peptides, 5, 967-973 (1984).
O. Mayer et al, Arzneim. Forsch., 21 (2), 298-303 (1971).
M. Vojtechovsky, Act. Nerv. Super., 7(3), 269 (1965).
V. Vitek et al, Psychopharmacologia, 7(3), 203-219 (1965).
G. E. Crane, Comp. Psychiat., 2, 51-53 (1961).
J. Simeon et al., Compri, Psychiat., 11, 80-88 (1970).
Martindale, The Extra Pharmacopoeia, p. 1152 28th Ed (1982).

Affiliated with

Also associated with

Rating

Use of a Glycine B partial agonist as an antipsychotic does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of a Glycine B partial agonist as an antipsychotic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a Glycine B partial agonist as an antipsychotic will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2148191